Ilika Plc Successfully passes annual ISO9001:2015 surveillance audit

Ilika plc

Ilika plc (LON: IKA), the advanced solid-state battery technology company, announced today that it has successfully passed its annual ISO9001:2015 surveillance audit and has retained its certification.

In January 2018, Ilika announced that its Quality Management System (QMS) for the development of solid-state batteries and materials research and development programmes had been assessed and found to meet the requirements of ISO9001:2015 by DAS certification. Over the past year Ilika has continued to refine and implement its QMS. As part of the standard monitoring of ISO9001:2015 certification holders, Ilika has recently been audited and confirmed to be in compliance, resulting in a recertification.

Graeme Purdy, Ilika plc CEO, commented on the news,

“An important component of the implementation of our licensing business model is preparing our technology for transfer into a manufacturing environment. ISO9001:2015 gives Ilika a structured framework for interacting with manufacturing partners like Semefab, who also have a similarly certified QMS.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search